Skin Cancer Resource Center
Featured Content

Treatment Considerations for Rare Skin Cancers

Dr. Christopher Miller, MD, Director of the Penn Dermatology Oncology Center, discusses rare skin cancers which are frequently misdiagnosed and have a high recurrence.

Second Opinion Boosts Melanoma Diagnostic Accuracy  

Unlike other cancer diagnoses that rely on objective measures, melanoma is often diagnosed based on a pathologist’s subjective assessment of a skin biopsy. With such an approach, it’s no wonder skin cancer biopsies are linked with some of the most unreliable readings.

Read More

 

 

Cutting-Edge Technology in Use for Stage I & II Skin Cancers

Dr. Christopher Miller, MD, Director of the Penn Dermatology Oncology Center, discusses his group’s contributions and advancements in treating stage I and II melanomas that arise in special sites.
Loading